Subcutaneous Infliximab+ustekinumab
Topic
In the 31 days to Nov 13, 2026, Subcutaneous Infliximab+ustekinumab was mentioned 15 times in the newsletters tracked by NewsletterScan, down 100% in the latest 15 days compared with the 16 days before. Most coverage came from Atomic IBD.See all newsletters covering Subcutaneous Infliximab+ustekinumab →
15
Volume
+0%
Growth
30 DaysUpgrade for full history
Loading chart...
About The Topic
"Subcutaneous Infliximab+ustekinumab" was mentioned 15 times in newsletters in the 31 days to Nov 13, 2026 (down 100% in the latest 15 days). Trends, top newsletters and related topics on NewsletterScan.
Channel Breakdown
Upgrade to unlock
View PlansKey Indicators
Upgrade to unlock
View PlansRelated Topics
R
Remote Work
86.67%
32 mentionsDeclining
D
Draft
50%
23 mentionsDeclining
1
10-year Treasury Yield
+100%
18 mentionsExploding
1
10almonds
+0%
16 mentionsPeaked
S
Stock Investing
+66.67%
16 mentionsExploding
S
Social Media
+0%
14 mentionsPeaked
P
Playoffs
+0%
13 mentionsPeaked
P
Podcast
+400%
13 mentionsExploding
S
Startup Fundraising
+100%
12 mentionsExploding
Explore more:Health Trends ·All Trending Topics ·Newsletters ·Weekly Insights ·Compare Topics